We are studying a new gene therapy combined with chemotherapy to see if it is safe and effective for patients with locally advanced pancreatic cancer. The trial will help determine the best dose and how well this treatment works.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pancreatic cancer is a type of cancer that begins in the pancreas, often presenting as ductal adenocarcinoma. It can be locally advanced and non-resectable, meaning it cannot be surgically removed, leading to serious health challenges.
Locally advanced pancreatic cancer refers to a stage of pancreatic cancer where the tumor has spread to nearby tissues but has not metastasized to distant organs. This type is often non-resectable, making treatment more complex.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.